| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
16.7 |
% |
10.6019/CHEMBL4513141 |
| Bos taurus |
Cytosol aminopeptidase |
IC50 |
0.5 |
nM |
10.1016/j.bmc.2011.01.008 |
| Bos taurus |
Cytosol aminopeptidase |
Ki |
500.0 |
nM |
10.1016/j.bmc.2012.06.041 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
Inhibition |
0.73 |
% |
10.6019/CHEMBL4513141 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Chlorocebus sabaeus |
Vero |
CC50 |
25000.0 |
nM |
10.1016/j.ejmech.2017.07.048 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-0.18 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
GI |
nan |
None |
10.1016/j.ejmech.2018.11.074 |
| Escherichia coli |
Escherichia coli |
Inhibition |
-1.57 |
% |
10.6019/CHEMBL4513141 |
| Homo sapiens |
A549 |
GI |
48.0 |
% |
10.1016/j.bmc.2016.08.054 |
| Homo sapiens |
A549 |
IC50 |
15930.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
A549 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
A549 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2018.04.041 |
| Homo sapiens |
A549 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2019.01.041 |
| Homo sapiens |
A549 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| Homo sapiens |
A549 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
A549 |
IC50 |
512900.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
AGS |
IC50 |
200000.0 |
nM |
10.1021/acsmedchemlett.1c00504 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Aminopeptidase B |
IC50 |
160000.0 |
nM |
10.1021/acsmedchemlett.6b00099 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
0.81 |
ug.mL-1 |
10.1021/jm970624o |
| Homo sapiens |
Aminopeptidase N |
IC50 |
100.0 |
ug.mL-1 |
10.1016/s0960-894x(99)00034-7 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
800.0 |
nM |
10.1016/j.ejmech.2017.07.048 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
2400.0 |
nM |
10.1016/j.ejmech.2009.12.071 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
2500.0 |
nM |
10.1016/j.bmcl.2013.06.058 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
2700.0 |
nM |
10.1016/s0960-894x(03)00550-x |
| Homo sapiens |
Aminopeptidase N |
IC50 |
3500.0 |
nM |
10.1016/j.bmc.2011.01.008 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
3900.0 |
nM |
10.1016/j.bmcl.2004.10.010 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
16000.0 |
nM |
10.1021/ml3000758 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
16270.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
17290.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
17340.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
19400.0 |
nM |
10.1016/S0960-894X(01)80519-9 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
20120.0 |
nM |
10.1016/j.bmc.2013.01.068 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
20120.0 |
nM |
10.1016/j.ejmech.2015.11.021 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
22890.0 |
nM |
10.1016/j.bmc.2011.07.008 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
29670.0 |
nM |
10.1016/j.bmc.2011.08.041 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
29670.0 |
nM |
10.1016/j.bmc.2012.06.024 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
34350.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
35500.0 |
nM |
10.1016/j.bmc.2018.04.041 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
35500.0 |
nM |
10.1016/j.bmc.2019.01.041 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
40000.0 |
nM |
10.1016/j.bmc.2012.04.035 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
40000.0 |
nM |
10.1016/j.bmcl.2013.03.021 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
40650.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
54700.0 |
nM |
10.1016/j.bmc.2018.04.041 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
54700.0 |
nM |
10.1016/j.bmc.2019.01.041 |
| Homo sapiens |
Aminopeptidase N |
IC50 |
471600.0 |
nM |
10.1016/s0960-894x(99)00034-7 |
| Homo sapiens |
Aminopeptidase N |
Inhibition |
77.6 |
% |
10.1016/j.ejmech.2017.07.048 |
| Homo sapiens |
Aminopeptidase N |
Inhibition |
85.0 |
% |
10.1021/jm021109f |
| Homo sapiens |
Aminopeptidase N |
Inhibition |
nan |
% |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
Aminopeptidase N |
Inhibition |
nan |
% |
10.1016/j.bmcl.2019.05.027 |
| Homo sapiens |
Aminopeptidase N |
Ki |
2370.0 |
nM |
10.1021/acs.jmedchem.9b00757 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
398.1 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Potency |
12995.3 |
nM |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bromodomain-containing protein 4 |
Delta TM |
-0.66 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Casein kinase I delta |
Delta TM |
0.13 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cerebroside-sulfatase |
Potency |
849.2 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclin-dependent kinase 2 |
Delta TM |
1.32 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dipeptidyl peptidase IV |
IC50 |
100.0 |
ug.mL-1 |
10.1016/s0960-894x(99)00034-7 |
| Homo sapiens |
Dipeptidyl peptidase IV |
IC50 |
100.0 |
ug.mL-1 |
10.1021/jm970624o |
| Homo sapiens |
Dipeptidyl peptidase IV |
IC50 |
324300.0 |
nM |
10.1016/s0960-894x(99)00034-7 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endoplasmic reticulum aminopeptidase 1 |
IC50 |
45000.0 |
nM |
10.1021/acs.jmedchem.2c00904 |
| Homo sapiens |
Endoplasmic reticulum aminopeptidase 1 |
IC50 |
50000.0 |
nM |
10.1021/acsmedchemlett.6b00084 |
| Homo sapiens |
Endoplasmic reticulum aminopeptidase 2 |
IC50 |
100000.0 |
nM |
10.1021/acs.jmedchem.2c00904 |
| Homo sapiens |
Endoplasmic reticulum aminopeptidase 2 |
Inhibition |
100.0 |
% |
10.1016/j.ejmech.2020.113053 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
ES-2 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2020.112679 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Fibroblast |
Growth Rate |
-0.85 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.72 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.83 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.91 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast growth factor receptor 3 |
Delta TM |
0.78 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
8436.8 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
20000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Delta TM |
0.33 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
HCT-116 |
IC50 |
44060.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
HCT-116 |
IC50 |
315250.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| Homo sapiens |
HCT-116 |
IC50 |
357610.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
HCT-116 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2018.04.041 |
| Homo sapiens |
HCT-116 |
IC50 |
1000000.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
HCT-116 |
Ratio IC50 |
1.83 |
None |
10.1016/j.bmc.2016.12.048 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.14 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.49 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.55 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.59 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.92 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.98 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEL |
IC50 |
416650.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| Homo sapiens |
HEL |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
HeLa |
IC50 |
154900.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
HeLa |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
HeLa |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| Homo sapiens |
HeLa |
Inhibition |
28.0 |
% |
10.1016/j.ejmech.2017.07.048 |
| Homo sapiens |
HepG2 |
IC50 |
14520.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
HepG2 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| Homo sapiens |
HepG2 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
HepG2 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2020.112679 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase |
IC50 |
nan |
None |
10.1016/j.bmc.2013.12.025 |
| Homo sapiens |
Histone deacetylase 1/3/5/8 |
IC50 |
100000.0 |
nM |
10.1016/j.bmc.2013.01.068 |
| Homo sapiens |
Histone deacetylase 1/3/5/8 |
IC50 |
1000000.0 |
nM |
10.1016/j.bmcl.2013.06.058 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
0.45 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
2.33 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase (HDAC1 and HDAC2) |
IC50 |
100000.0 |
nM |
10.1016/j.ejmech.2015.11.021 |
| Homo sapiens |
Histone deacetylase (HDAC1 and HDAC2) |
Inhibition |
nan |
% |
10.1016/j.bmc.2015.09.013 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
HL-60 |
EC50 |
100000.0 |
nM |
10.1016/j.ejmech.2017.07.048 |
| Homo sapiens |
HL-60 |
IC50 |
86400.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
HL-60 |
IC50 |
245000.0 |
nM |
10.1016/j.bmcl.2011.12.048 |
| Homo sapiens |
HL-60 |
IC50 |
245000.0 |
nM |
10.1016/j.ejmech.2009.07.022 |
| Homo sapiens |
HL-60 |
IC50 |
920000.0 |
nM |
10.1016/j.bmc.2009.02.034 |
| Homo sapiens |
HL-60 |
IC50 |
920000.0 |
nM |
10.1016/j.bmc.2009.07.014 |
| Homo sapiens |
HL-60 |
IC50 |
1130000.0 |
nM |
10.1016/j.bmc.2010.06.078 |
| Homo sapiens |
HL-60 |
IC50 |
1340000.0 |
nM |
10.1016/j.bmc.2011.07.008 |
| Homo sapiens |
HL-60 |
IC50 |
1650000.0 |
nM |
10.1016/j.bmc.2008.10.025 |
| Homo sapiens |
HL-60 |
IC50 |
1650000.0 |
nM |
10.1016/j.bmc.2009.04.038 |
| Homo sapiens |
HL-60 |
IC50 |
nan |
None |
10.1016/j.bmc.2016.08.054 |
| Homo sapiens |
HL60/MX2 |
IC50 |
nan |
None |
10.1016/j.bmc.2016.08.054 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
HT-1080 |
Activity |
10.0 |
% |
10.1016/j.bmc.2010.02.056 |
| Homo sapiens |
HUVEC |
Activity |
nan |
None |
10.1016/j.bmcl.2013.03.021 |
| Homo sapiens |
HUVEC |
Activity |
nan |
None |
10.1016/j.ejmech.2016.05.068 |
| Homo sapiens |
HUVEC |
Activity |
nan |
None |
10.1021/acsmedchemlett.1c00504 |
| Homo sapiens |
HUVEC |
Activity |
nan |
None |
10.1021/ml3000758 |
| Homo sapiens |
HUVEC |
IC50 |
2000000.0 |
nM |
10.1016/j.bmc.2019.01.041 |
| Homo sapiens |
HUVEC |
Inhibition |
nan |
% |
10.1016/j.bmc.2012.12.038 |
| Homo sapiens |
HUVEC |
Inhibition |
nan |
% |
10.1016/j.bmc.2018.04.041 |
| Homo sapiens |
HUVEC |
Inhibition |
nan |
% |
10.1016/j.bmc.2019.01.041 |
| Homo sapiens |
HUVEC |
Inhibition |
nan |
% |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
Interleukin-1 receptor antagonist protein |
IC50 |
100000.0 |
nM |
10.1021/acs.jmedchem.2c00904 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
K562 |
IC50 |
135600.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
K562 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
K562 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2018.04.041 |
| Homo sapiens |
K562 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2019.01.041 |
| Homo sapiens |
K562 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2020.112679 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
KG-1 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
KG-1 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| Homo sapiens |
Leucine aminopeptidase |
IC50 |
11200.0 |
nM |
10.1016/j.bmcl.2004.10.010 |
| Homo sapiens |
Leucine aminopeptidase |
Ki |
0.6 |
nM |
10.1021/jm030795v |
| Homo sapiens |
Leucine aminopeptidase |
Ki |
20.0 |
nM |
10.1021/jm00119a022 |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukotriene A4 hydrolase |
Delta Tm |
5.1 |
degrees C |
10.1016/j.bmc.2016.08.047 |
| Homo sapiens |
Leukotriene A4 hydrolase |
Delta Tm |
5.2 |
degrees C |
10.1016/j.bmc.2016.08.047 |
| Homo sapiens |
Leukotriene A4 hydrolase |
IC50 |
266.0 |
nM |
10.1021/acsmedchemlett.0c00102 |
| Homo sapiens |
Leukotriene A4 hydrolase |
IC50 |
300.0 |
nM |
10.1016/j.bmc.2016.08.047 |
| Homo sapiens |
Leukotriene A4 hydrolase |
IC50 |
500.0 |
nM |
10.1016/j.bmc.2011.01.008 |
| Homo sapiens |
Leukotriene A4 hydrolase |
IC50 |
4000.0 |
nM |
10.1016/j.bmcl.2008.07.043 |
| Homo sapiens |
Leukotriene A4 hydrolase |
IC50 |
4000.0 |
nM |
10.1016/S0960-894X(01)80464-9 |
| Homo sapiens |
Leukotriene A4 hydrolase |
IC50 |
4200.0 |
nM |
10.1016/j.ejmech.2012.10.057 |
| Homo sapiens |
Leukotriene A4 hydrolase |
IC50 |
10100.0 |
nM |
10.1016/j.bmc.2016.12.048 |
| Homo sapiens |
Leukotriene A4 hydrolase |
IC50 |
18010.0 |
nM |
10.1016/j.bmc.2016.12.048 |
| Homo sapiens |
Leukotriene A4 hydrolase |
Kd |
2050.0 |
nM |
10.1016/j.bmc.2016.08.047 |
| Homo sapiens |
Leukotriene A4 hydrolase |
Kd |
4630.0 |
nM |
10.1016/j.bmc.2016.08.047 |
| Homo sapiens |
Leukotriene A4 hydrolase |
Kd |
5150.0 |
nM |
10.1016/j.bmc.2016.08.047 |
| Homo sapiens |
Leukotriene A4 hydrolase |
Ki |
320.0 |
nM |
10.1016/j.bmc.2016.08.047 |
| Homo sapiens |
LoVo |
GI |
54.8 |
% |
10.1016/j.bmc.2016.08.054 |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Delta TM |
0.15 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 14 |
IC50 |
nan |
nM |
10.1016/j.bmcl.2004.10.010 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
3400.0 |
nM |
10.1016/j.bmcl.2006.12.095 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
9500.0 |
nM |
10.1016/j.bmc.2008.05.081 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
21960.0 |
nM |
10.1016/j.bmc.2008.04.012 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
40500.0 |
nM |
10.1016/j.bmc.2009.02.063 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
40500.0 |
nM |
10.1016/j.bmc.2009.03.017 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
100000.0 |
nM |
10.1016/j.bmc.2013.12.025 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
120400.0 |
nM |
10.1016/j.bmc.2011.07.008 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
156000.0 |
nM |
10.1016/j.bmc.2012.04.035 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
156000.0 |
nM |
10.1016/j.bmcl.2013.03.021 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
156980.0 |
nM |
10.1016/j.bmc.2010.06.078 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
162000.0 |
nM |
10.1016/j.bmc.2008.10.025 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
162000.0 |
nM |
10.1016/j.bmc.2009.04.056 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
162000.0 |
nM |
10.1016/j.bmc.2009.07.014 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
163480.0 |
nM |
10.1016/j.bmc.2011.08.041 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
253200.0 |
nM |
10.1016/j.bmc.2009.11.036 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
276000.0 |
nM |
10.1021/ml3000758 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
nan |
nM |
10.1016/j.bmcl.2004.10.010 |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
nan |
None |
10.1016/j.bmc.2015.09.013 |
| Homo sapiens |
Matrix metalloproteinase-2 |
Inhibition |
nan |
% |
10.1016/j.bmc.2015.09.013 |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
nM |
10.1016/j.bmcl.2004.10.010 |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
10.1016/j.bmc.2015.09.013 |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Inhibition |
nan |
% |
10.1016/j.bmc.2015.09.013 |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MCF10 |
GI |
26.9 |
% |
10.1016/j.bmc.2016.08.054 |
| Homo sapiens |
MCF7 |
Activity |
3.4 |
% |
10.1021/acs.jmedchem.6b00190 |
| Homo sapiens |
MCF7 |
Activity |
7.5 |
% |
10.1021/acs.jmedchem.6b00190 |
| Homo sapiens |
MCF7 |
Activity |
nan |
None |
10.1021/acs.jmedchem.6b00190 |
| Homo sapiens |
MCF7 |
GI |
63.8 |
% |
10.1016/j.bmc.2016.08.054 |
| Homo sapiens |
MCF7 |
IC50 |
149600.0 |
nM |
10.1016/j.bmc.2016.08.054 |
| Homo sapiens |
MCF7 |
IC50 |
200000.0 |
nM |
10.1021/acsmedchemlett.1c00504 |
| Homo sapiens |
MCF7 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| Homo sapiens |
MCF7 |
IC50 |
541000.0 |
nM |
10.1021/acs.jmedchem.6b00190 |
| Homo sapiens |
MCF7 |
IC50 |
1000000.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
MDA-MB-231 |
Activity |
2.14 |
% |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
MDA-MB-231 |
Activity |
7.03 |
% |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
MDA-MB-231 |
Activity |
8.54 |
% |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
MDA-MB-231 |
Activity |
15.06 |
% |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
MDA-MB-231 |
Activity |
77.91 |
% |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
MDA-MB-231 |
Activity |
nan |
None |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
MDA-MB-231 |
Activity |
nan |
None |
10.1016/j.bmcl.2019.05.027 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
50600.0 |
nM |
10.1016/j.bmc.2012.06.024 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
50600.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2018.04.041 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
753180.0 |
nM |
10.1016/j.bmc.2011.08.041 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
5080000.0 |
nM |
10.1016/j.bmc.2011.07.008 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
8590000.0 |
nM |
10.1016/j.bmc.2010.06.078 |
| Homo sapiens |
MDA-MB-435 |
Inhibition |
nan |
% |
10.1016/j.bmcl.2013.04.031 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
MOLT-4 |
EC50 |
100000.0 |
nM |
10.1016/j.ejmech.2017.07.048 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
MRC5 |
IC50 |
nan |
None |
10.1021/jm301506h |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
NB-4 |
IC50 |
220900.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
NCI-H1975 |
IC50 |
200000.0 |
nM |
10.1021/acsmedchemlett.1c00504 |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neutrophil |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.9b00663 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
8199.5 |
nM |
None |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
PANC-1 |
Activity |
10.0 |
% |
10.1016/j.bmc.2010.02.056 |
| Homo sapiens |
PC-3 |
IC50 |
399400.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
PC-3 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
PC-3 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2018.04.041 |
| Homo sapiens |
PC-3 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2019.01.041 |
| Homo sapiens |
PC-3 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| Homo sapiens |
PC-3 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2020.112679 |
| Homo sapiens |
Peregrin |
Delta TM |
-2.93 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Phospholipase A2 group IIA |
IC50 |
100000.0 |
nM |
10.1016/j.ejmech.2012.10.057 |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
PLC |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2018.04.041 |
| Homo sapiens |
PLC |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2019.01.041 |
| Homo sapiens |
PLC-PRF-5 |
Activity |
0.0 |
% |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
PLC-PRF-5 |
Activity |
0.01 |
% |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
PLC-PRF-5 |
Activity |
2.38 |
% |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
PLC-PRF-5 |
Activity |
3.59 |
% |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
PLC-PRF-5 |
Activity |
7.1 |
% |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
PLC-PRF-5 |
Activity |
11.0 |
% |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
PLC-PRF-5 |
Activity |
13.0 |
% |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
PLC-PRF-5 |
Activity |
33.3 |
% |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
PLC-PRF-5 |
Activity |
64.3 |
% |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
PLC-PRF-5 |
Activity |
83.4 |
% |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
PLC-PRF-5 |
Activity |
nan |
None |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
PLC-PRF-5 |
IC50 |
22810.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
PLC-PRF-5 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
PLC-PRF-5 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| Homo sapiens |
PLC-PRF-5 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
PLC-PRF-5 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2020.112679 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Puromycin-sensitive aminopeptidase |
IC50 |
3500.0 |
nM |
10.1016/j.ejmech.2017.07.048 |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Delta TM |
-0.07 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
SH-SY5Y |
Potency |
398.1 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
SK-OV-3 |
IC50 |
1000000.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Homo sapiens |
Solute carrier family 15 member 2 |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
10.9 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
31.8 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
20.7 |
% |
10.1021/jm300212s |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Transcription intermediary factor 1-alpha |
Delta TM |
-0.82 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Delta TM |
-0.05 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
U-266 |
IC50 |
43480.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
U-266 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
U-266 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
U2OS |
Growth Rate |
0.42 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.82 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.89 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.94 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U-937 |
Cytotoxicity |
40.0 |
% |
10.1021/jm021109f |
| Homo sapiens |
U-937 |
IC50 |
9560.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
U-937 |
IC50 |
142630.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Homo sapiens |
U-937 |
IC50 |
142630.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Homo sapiens |
U-937 |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2018.04.041 |
| Homo sapiens |
U-937 |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2020.112679 |
| Homo sapiens |
U-937 |
IC50 |
1000000.0 |
nM |
10.1016/j.bmc.2013.01.068 |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
12.45 |
% |
10.6019/CHEMBL4513141 |
| Mus musculus |
3LL cell line |
Inhibition |
50.0 |
% |
10.1021/ml3000758 |
| Mus musculus |
Aminopeptidase B |
IC50 |
6000.0 |
nM |
10.1016/S0960-894X(01)80519-9 |
| Mus musculus |
Aminopeptidase N |
IC50 |
23200.0 |
nM |
10.1021/ml3000758 |
| Mus musculus |
Aminopeptidase N |
Ki |
3030.0 |
nM |
10.1021/ml3000758 |
| Mus musculus |
B16-BL6 |
Inhibition |
50.0 |
% |
10.1021/ml3000758 |
| Mus musculus |
BALB/3T3 |
GI |
37.7 |
% |
10.1016/j.bmc.2016.08.054 |
| Mus musculus |
H22 |
Activity |
60.25 |
% |
10.1016/j.ejmech.2009.07.022 |
| Mus musculus |
H22 |
Activity |
64.0 |
% |
10.1016/j.bmc.2018.04.041 |
| Mus musculus |
H22 |
Activity |
nan |
None |
10.1016/j.bmc.2019.01.041 |
| Mus musculus |
H22 |
Inhibition |
45.37 |
% |
10.1016/j.bmcl.2011.12.048 |
| Mus musculus |
H22 |
Inhibition |
75.9 |
% |
10.1016/j.ejmech.2015.11.021 |
| Mus musculus |
H22 |
TGI |
45.37 |
% |
10.1016/j.ejmech.2009.12.071 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.6b01507 |
| Mus musculus |
Mus musculus |
Change |
-3.0 |
% |
10.1021/jm00083a013 |
| Mus musculus |
Mus musculus |
Change |
3.0 |
% |
10.1021/jm00083a013 |
| Mus musculus |
Mus musculus |
Change |
11.0 |
% |
10.1021/jm00083a013 |
| Mus musculus |
Mus musculus |
Change |
26.0 |
% |
10.1021/jm00083a013 |
| Mus musculus |
Mus musculus |
Change |
41.0 |
% |
10.1021/jm00083a013 |
| Mus musculus |
Mus musculus |
Change |
59.0 |
% |
10.1021/jm00083a013 |
| Mus musculus |
Mus musculus |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.6b01507 |
| Mus musculus |
NIH3T3 |
IC50 |
1000000.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Plasminogen/Urokinase plasminogen activator surface receptor/Urokinase-type plasminogen activator |
Potency |
16481.6 |
nM |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Plasmodium chabaudi |
Plasmodium chabaudi |
Activity |
34.0 |
% |
10.1021/acs.jmedchem.0c01721 |
| Plasmodium falciparum |
Plasmodium falciparum |
Activity |
36.0 |
% |
10.1016/j.bmc.2017.06.047 |
| Plasmodium falciparum |
Plasmodium falciparum |
Activity |
nan |
None |
10.1074/jbc.m703643200 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
900.0 |
nM |
10.1074/jbc.m703643200 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
1800.0 |
nM |
10.1074/jbc.m703643200 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
5100.0 |
nM |
10.1128/aac.00840-06 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
nan |
None |
10.1128/aac.00840-06 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
8.0 |
nM |
10.1021/jm301506h |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
3200.0 |
nM |
10.1021/jm101227t |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
3300.0 |
nM |
10.1016/j.bmc.2017.06.047 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
5000.0 |
nM |
10.1021/acs.jmedchem.0c01721 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
14870.0 |
nM |
10.1021/acs.jmedchem.0c01721 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
21000.0 |
nM |
10.1016/j.bmc.2017.06.047 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
29000.0 |
nM |
10.1016/s0960-894x(03)00550-x |
| Plasmodium falciparum |
Plasmodium falciparum |
Inhibition |
29.0 |
% |
10.1128/aac.01327-07 |
| Plasmodium falciparum |
Plasmodium falciparum |
Inhibition |
97.0 |
% |
10.1128/aac.01327-07 |
| Plasmodium falciparum 3D7 |
M17 leucyl aminopeptidase |
Inhibition |
6.0 |
% |
10.1128/aac.01327-07 |
| Plasmodium falciparum 3D7 |
M17 leucyl aminopeptidase |
Inhibition |
33.0 |
% |
10.1128/aac.01327-07 |
| Plasmodium falciparum 3D7 |
M17 leucyl aminopeptidase |
Inhibition |
47.0 |
% |
10.1128/aac.01327-07 |
| Plasmodium falciparum 3D7 |
M17 leucyl aminopeptidase |
Inhibition |
93.0 |
% |
10.1128/aac.01327-07 |
| Plasmodium falciparum 3D7 |
M17 leucyl aminopeptidase |
Inhibition |
98.0 |
% |
10.1128/aac.01327-07 |
| Plasmodium falciparum FcB1/Columbia |
Zinc aminopeptidase |
IC50 |
284.0 |
nM |
10.1016/s0960-894x(03)00550-x |
| Plasmodium falciparum FcB1/Columbia |
Zinc aminopeptidase |
Ki |
190.0 |
nM |
10.1021/jm101227t |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
8.82 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Aminopeptidase B |
IC50 |
0.05 |
ug.mL-1 |
10.1021/jm00214a010 |
| Rattus norvegicus |
Aminopeptidase B |
IC50 |
6000.0 |
nM |
10.1021/jm00083a013 |
| Rattus norvegicus |
Aminopeptidase B |
Ki |
14.0 |
nM |
10.1021/jm00126a039 |
| Rattus norvegicus |
Aminopeptidase B |
Ki |
60.0 |
nM |
10.1021/jm00119a022 |
| Rattus norvegicus |
Aminopeptidase N |
IC50 |
19400.0 |
nM |
10.1021/jm00083a013 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Aorta |
Activity |
nan |
None |
10.1016/j.bmcl.2013.03.021 |
| Rattus norvegicus |
Aorta |
Activity |
nan |
None |
10.1016/j.ejmech.2016.05.068 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cystinyl aminopeptidase |
Ki |
20.0 |
nM |
10.1021/jm00126a039 |
| Rattus norvegicus |
Cystinyl aminopeptidase |
Ki |
4400.0 |
nM |
10.1021/jm00126a039 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Oligopeptide transporter, kidney isoform |
Activity |
nan |
None |
10.1016/0005-2736(96)00024-7 |
| Rattus norvegicus |
Oligopeptide transporter, kidney isoform |
Ki |
18000.0 |
nM |
10.1007/s004240000339 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
40000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41800.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
42200.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
42300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
43000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
289.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
304.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
308.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
310.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
334.17 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
345.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
48.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
50.83 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
53.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
54.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
55.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
58.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
76.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
82.17 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
87.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
92.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
93.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
96.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AUC |
11499.0 |
ng.hr.mL-1 |
10.1016/j.ejmech.2017.11.074 |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.2 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
140.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
155.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
156.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
163.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
165.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
166.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
99.83 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
100.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
102.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
103.5 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
105.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
108.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
583.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
623.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
633.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
760.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
785.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
800.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
244.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
272.17 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
350.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
381.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
463.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
475.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CL |
115.95 |
mL.min-1.kg-1 |
10.1016/j.ejmech.2017.11.074 |
| Rattus norvegicus |
Rattus norvegicus |
Cmax |
7458.33 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
23670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
25670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
26500000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
29330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
31330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.8 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.1 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.6 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
28.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
88.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
99.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
168.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
1.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1420.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1430.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1463.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1556.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1618.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1976.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
33.13 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
35.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
35.73 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
36.13 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
36.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
129700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
139700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
140300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
140700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
141000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
143300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
157.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
228.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
237.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
487.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
498.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
612.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.17 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12244.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12669.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
13539.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
13654.17 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
13954.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
15131.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
85.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
86.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
88.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
89.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
89.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
94.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.33 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.9 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.42 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.53 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.6 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.63 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
387700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
390000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
391700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
395300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
401700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
403700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
59.53 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
60.93 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
61.37 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
61.53 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.05 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.55 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
91.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
121.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
122.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
144.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
177.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
277.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
2.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MRT |
3.436 |
hr |
10.1016/j.ejmech.2017.11.074 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
5.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
8.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
8.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
10.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
12.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
13.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
847.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1191.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1223.17 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1655.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1690.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
2116.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
92.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
105.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
110.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
112.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
118.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
121.8 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1144330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1187670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1238330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1252670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1281170.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1312170.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.18 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.71 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.1 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.4 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.61 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.78 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
57000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
58000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
58500.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
60300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
61000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
62200.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5560000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5700000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5720000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5780000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5820000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5870000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.17 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
142.5 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.5 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.9 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
144.27 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
146.95 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
150.27 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
T1/2 |
3.404 |
hr |
10.1016/j.ejmech.2017.11.074 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
12.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
13.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
14.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
15.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
17.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
18.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Vd |
34.18 |
L.kg-1 |
10.1016/j.ejmech.2017.11.074 |
| Rattus norvegicus |
Rattus norvegicus |
VRT |
13.09 |
hr2 |
10.1016/j.ejmech.2017.11.074 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14170.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
15170.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
15800.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
15830.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
16100.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier family 15 member 1 |
Activity |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier family 15 member 1 |
Ki |
1500000.0 |
nM |
10.1007/s004240000339 |
| Rattus norvegicus |
Thoracic aorta |
Activity |
nan |
None |
10.1016/j.bmc.2018.04.041 |
| Rattus norvegicus |
Thoracic aorta |
Activity |
nan |
None |
10.1016/j.bmc.2019.01.041 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
11.61 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
17.76 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
20.76 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1422 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.12 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.08 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.11 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
1.62 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.01222 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
8.9 |
% |
10.6019/CHEMBL4513141 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
5.0 |
nM |
10.1021/jm00147a007 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
1300.0 |
nM |
10.1016/j.bmc.2012.06.024 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
1640.0 |
nM |
10.1016/j.bmc.2013.12.025 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
2100.0 |
nM |
10.1016/j.bmc.2010.02.056 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
2100.0 |
nM |
10.1016/j.bmcl.2008.05.050 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
2400.0 |
nM |
10.1016/j.bmcl.2006.12.095 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
2400.0 |
nM |
10.1016/j.ejmech.2009.07.022 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
2450.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
2700.0 |
nM |
10.1016/j.bmc.2006.10.010 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
3000.0 |
nM |
10.1016/j.bmc.2009.04.038 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
3100.0 |
nM |
10.1016/j.bmc.2008.10.025 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
3100.0 |
nM |
10.1016/j.bmc.2009.02.034 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
3400.0 |
nM |
10.1016/j.bmc.2013.01.068 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
3400.0 |
nM |
10.1016/j.ejmech.2015.11.021 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
3600.0 |
nM |
10.1016/j.bmc.2009.07.014 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
3640.0 |
nM |
10.1021/acsmedchemlett.1c00504 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
3700.0 |
nM |
10.1016/j.bmc.2011.07.008 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
3700.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
3800.0 |
nM |
10.1016/j.bmc.2009.04.056 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
3800.0 |
nM |
10.1016/j.bmc.2009.11.036 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
4180.0 |
nM |
10.1016/j.bmc.2010.06.078 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
5120.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
5550.0 |
nM |
10.1016/j.bmc.2011.08.041 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
5580.0 |
nM |
10.1016/j.bmcl.2013.06.058 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
5870.0 |
nM |
10.1016/j.bmc.2010.11.066 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
6900.0 |
nM |
10.1016/j.bmc.2015.09.013 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
8100.0 |
nM |
10.1016/j.bmc.2012.04.035 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
8100.0 |
nM |
10.1016/j.bmcl.2013.03.021 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
8500.0 |
nM |
10.1016/j.bmc.2008.05.081 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
8900.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
9100.0 |
nM |
10.1021/ml3000758 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
9400.0 |
nM |
10.1016/j.bmc.2018.04.041 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
9400.0 |
nM |
10.1016/j.bmc.2019.01.041 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
9400.0 |
nM |
10.1016/j.ejmech.2020.112679 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
13100.0 |
nM |
10.1016/j.bmc.2009.02.063 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
13100.0 |
nM |
10.1016/j.bmc.2009.03.017 |
| Sus scrofa |
Aminopeptidase N |
IC50 |
14900.0 |
nM |
10.1021/acs.jmedchem.7b00782 |
| Sus scrofa |
Aminopeptidase N |
Inhibition |
48.6 |
% |
10.1021/acs.jmedchem.2c01257 |
| Sus scrofa |
Aminopeptidase N |
Ki |
0.5 |
nM |
10.1016/j.bmc.2012.06.041 |
| Sus scrofa |
Aminopeptidase N |
Ki |
2100.0 |
nM |
10.1016/j.bmc.2017.06.047 |
| Sus scrofa |
Aminopeptidase N |
Ki |
3500.0 |
nM |
10.1016/j.bmc.2013.08.044 |
| Sus scrofa |
Aminopeptidase N |
Ki |
3730.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| Sus scrofa |
Aminopeptidase N |
Ki |
7800.0 |
nM |
10.1021/jm00119a022 |
| Sus scrofa |
Cytosol aminopeptidase |
IC50 |
5200.0 |
nM |
10.1016/j.bmc.2016.08.054 |
| Sus scrofa |
Cytosol aminopeptidase |
IC50 |
11200.0 |
nM |
10.1016/j.bmc.2016.08.054 |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
8492.1 |
nM |
None |
| Vibrio proteolyticus |
Bacterial leucyl aminopeptidase |
Ki |
1.6 |
nM |
10.1016/j.bmc.2013.08.044 |
| None |
ADMET |
Drug metabolism |
nan |
None |
10.1016/j.ejmech.2017.11.074 |
| None |
ADMET |
GI |
1.0 |
% |
10.1021/ml3000758 |
| None |
ADMET |
GI |
2.89 |
% |
10.1021/ml3000758 |
| None |
ADMET |
GI50 |
500000.0 |
nM |
10.1021/ml3000758 |
| None |
Erythrocyte |
Activity |
nan |
None |
10.1016/j.bmc.2017.06.047 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1016/j.bmcl.2013.03.021 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1021/ml3000758 |
| None |
NON-PROTEIN TARGET |
GI50 |
350000.0 |
nM |
10.1016/j.bmcl.2013.03.021 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
2.4 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
100.0 |
ug.mL-1 |
10.1016/s0960-894x(99)00034-7 |
| None |
NON-PROTEIN TARGET |
IC50 |
42540.0 |
nM |
10.1016/j.bmc.2016.12.048 |
| None |
NON-PROTEIN TARGET |
IC50 |
74500.0 |
nM |
10.1016/j.bmcl.2012.07.086 |
| None |
NON-PROTEIN TARGET |
IC50 |
77820.0 |
nM |
10.1016/j.bmc.2016.12.048 |
| None |
NON-PROTEIN TARGET |
IC50 |
89510.0 |
nM |
10.1016/j.bmc.2016.12.048 |
| None |
NON-PROTEIN TARGET |
IC50 |
141890.0 |
nM |
10.1016/j.bmc.2011.08.041 |
| None |
NON-PROTEIN TARGET |
IC50 |
332000.0 |
nM |
10.1016/j.bmc.2010.11.066 |
| None |
NON-PROTEIN TARGET |
IC50 |
490000.0 |
nM |
10.1016/j.bmc.2012.04.035 |
| None |
NON-PROTEIN TARGET |
IC50 |
620000.0 |
nM |
10.1016/j.bmc.2013.01.068 |
| None |
NON-PROTEIN TARGET |
IC50 |
631740.0 |
nM |
10.1016/j.bmc.2012.06.024 |
| None |
NON-PROTEIN TARGET |
Inhibition |
nan |
% |
10.1016/j.bmc.2012.04.035 |
| None |
NON-PROTEIN TARGET |
Inhibition |
nan |
% |
10.1016/j.ejmech.2015.11.021 |
| None |
NON-PROTEIN TARGET |
TGI |
36.2 |
% |
10.1016/j.ejmech.2009.12.071 |
| None |
No relevant target |
Rf |
0.48 |
None |
10.1021/jm00214a010 |
| None |
No relevant target |
solubility |
nan |
None |
10.1021/jm900259h |
| None |
No relevant target |
Solubility |
35700000.0 |
nM |
10.1021/acs.jmedchem.7b00782 |
| None |
Unchecked |
Activity |
1.2 |
% |
10.1016/j.bmc.2017.06.047 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.bmc.2019.01.041 |
| None |
Unchecked |
Activity |
nan |
None |
10.1074/jbc.m703643200 |
| None |
Unchecked |
GI |
26.9 |
% |
10.1016/j.bmc.2016.08.054 |
| None |
Unchecked |
Hepatotoxicity (acute) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
0.01 |
ug.mL-1 |
10.1021/jm00214a010 |
| None |
Unchecked |
IC50 |
1.6 |
nM |
10.1016/j.bmc.2011.01.008 |
| None |
Unchecked |
IC50 |
170.0 |
nM |
10.1021/jm00119a023 |
| None |
Unchecked |
IC50 |
300.0 |
nM |
10.1021/jm00083a013 |
| None |
Unchecked |
IC50 |
310.0 |
nM |
10.1016/j.bmc.2017.06.047 |
| None |
Unchecked |
IC50 |
478.0 |
nM |
10.1021/jm301506h |
| None |
Unchecked |
IC50 |
4410.0 |
nM |
10.1016/j.bmcl.2011.02.068 |
| None |
Unchecked |
IC50 |
7000.0 |
nM |
10.1016/j.bmcl.2011.02.068 |
| None |
Unchecked |
IC50 |
7000.0 |
nM |
10.1016/j.ejmech.2018.11.074 |
| None |
Unchecked |
IC50 |
15500.0 |
nM |
10.1016/j.bmc.2008.04.012 |
| None |
Unchecked |
IC50 |
17580.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| None |
Unchecked |
IC50 |
25000.0 |
nM |
10.1016/j.bmcl.2011.02.068 |
| None |
Unchecked |
IC50 |
37050.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| None |
Unchecked |
IC50 |
200000.0 |
nM |
10.1021/jm901613f |
| None |
Unchecked |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2016.09.033 |
| None |
Unchecked |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2018.04.041 |
| None |
Unchecked |
IC50 |
500000.0 |
nM |
10.1016/j.bmc.2019.01.041 |
| None |
Unchecked |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2016.05.068 |
| None |
Unchecked |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2017.11.074 |
| None |
Unchecked |
IC50 |
nan |
None |
10.1016/j.bmc.2016.08.054 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
50.0 |
% |
10.1016/j.bmc.2017.06.047 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.8b01310 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/ml3000758 |
| None |
Unchecked |
Ki |
1.6 |
nM |
10.1021/acs.jmedchem.0c01721 |
| None |
Unchecked |
Ki |
25.0 |
nM |
10.1021/acs.jmedchem.0c01721 |
| None |
Unchecked |
Ki |
160.0 |
nM |
10.1016/j.bmc.2017.06.047 |
| None |
Unchecked |
Ki |
478.0 |
nM |
10.1021/acs.jmedchem.0c01721 |
| None |
Unchecked |
Ki |
478.2 |
nM |
10.1021/acs.jmedchem.0c01721 |
| None |
Unchecked |
Ki |
1530.0 |
nM |
10.1021/acs.jmedchem.9b00757 |
| None |
Unchecked |
Ki |
1673.0 |
nM |
10.1021/acs.jmedchem.0c01721 |
| None |
Unchecked |
Ki |
623000.0 |
nM |
10.1021/acs.jmedchem.0c01721 |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
31622.8 |
nM |
None |
| None |
Unchecked |
Ratio |
0.1 |
None |
10.1016/s0960-894x(03)00550-x |
| None |
Unchecked |
Ratio IC50 |
0.71 |
None |
10.1016/j.bmcl.2006.12.095 |
| None |
Unchecked |
Ratio IC50 |
30.2 |
None |
10.1021/ml3000758 |
| None |
Unchecked |
Ratio IC50 |
32.5 |
None |
10.1016/j.bmc.2011.07.008 |
| None |
Unchecked |
Ratio IC50 |
42.6 |
None |
10.1016/j.bmc.2009.04.056 |
| None |
Unchecked |
Ratio Ki |
13.1 |
None |
10.1016/j.bmc.2017.06.047 |